SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMolten Ventures Regulatory News (GROW)

Share Price Information for Molten Ventures (GROW)

Share Price is delayed by 15 minutes
Get Live Data
632.50    10.00 (1.61%)
Bid:
630.50
Ask:
633.00
Spread: 2.50 (0.397%)
Market Cap: £1.09b
GROW Live PriceLast checked at - London Stock Exchange

Intraday Molten Ventures Share Chart

Results analysis from Kepler Trust Intelligence

Today 11:29

RNS Number : 3325I
Molten Ventures PLC
15 June 2026
 

Molten Ventures (GROW)

15/06/2026

Results analysis from Kepler Trust Intelligence

Molten Ventures (GROW) has reported a 13% increase in gross portfolio value (GPV) over the year ending 31/03/2026, but this news has been overshadowed by the simultaneous announcement of an even greater post-period end gain, an implied 16% increase to GPV from the revaluation of ICEYE in a new funding round.

The share price return was 79% over FY 2025, as the discount narrowed markedly, from 62% to 38%. Post period end it has narrowed further and sits at 29% at the time of writing, incorporating the gains from the ICEYE revaluation.

In FY 2026, £120m was realized at an average 3x multiple of invested capital. Of this, £38m was spent on share buybacks, contributing 21p to the 89p total NAV per share uplift of 13%.

A partial realization of Revolut at 21x the invested capital was achieved, with a further £63m realized from Revolut after the period end. Some cash was also taken out of ICEYE at 12.9x invested capital.

On 09/06/2026, GROW announced it had realised a further £22m from ICEYE during a bumper Series F funding round which would make ICEYE the largest investment in the portfolio. At the value of the round, Molten's holding value in ICEYE will increase to £317 million, representing an uplift of £238 million (+236%) from the 31 March 2026 holding value. The new implied GPV of £317 million is after the proceeds of the secondary sale. This round is a striking validation of the business, which achieved EBITDA profitability over 2025.

Kepler View

Molten Ventures (GROW) experienced a year of recovery over 2025. A surging share price has been accompanied by an increase in exits in line with or above carrying value, validating the NAV. In the second half of the year, a major revaluation to Revolut was followed by big contract wins to ICEYE. In the new financial year, this has been followed up with a huge uplift to the value of the latter company thanks to a new funding round. However, even after such strong operational performance, the shares still trade on a 29% discount to NAV, which we think makes them look particularly attractive.

We think it is clear that activity at the more mature end of the VC market has picked up, and globally interest in late-stage private companies has risen too, with the US likely to see a number of blockbusting IPOs. Total capital raised in the sector in Europe was at its highest in 2025 since 2022, thanks to an increase in deals in the larger end of the market. This top-heavy nature has been reflected in the core of Molten's portfolio delivering its double digit NAV return for 2025, following on 4% for 2024 and -1% for 2023. The upwards trajectory has continued with ICEYE's funding round leading to an implied 16% increase in GROW's NAV alone this year. Molten's core delivered 26% fair value growth, while the emerging portfolio was written down by 21% and funds were up 17%. The core 17 companies make up 64% of the portfolio, so continued strength here will have the most impact on overall returns.

We think GROW continues to stand out for its exposure to new technology themes at what continues to be a cheap price, i.e. on a wide discount to NAV. With interest in space, defence sovereignty and new tech powered by AI only growing, and with risk appetite returning selectively to these themes, we think there is the potential for a revaluation which would be additive to the potential in the NAV.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABGGDLIDBDGLU
Date   Source Headline
15th Jun 202611:29 amRNS-RResults analysis from Kepler Trust Intelligence
10th Jun 202612:14 pmEQSHolding(s) in Company
10th Jun 20267:00 amEQS30 million euro investment in Isar Aerospace
9th Jun 20265:55 pmEQSHolding(s) in Company
9th Jun 20264:00 pmEQSAnnual Financial Report and Notice of AGM
9th Jun 20268:05 amEQSFINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2026
9th Jun 20267:00 amEQSICEYE Series F financing
8th Jun 20268:00 amRNS-RRelease of Monthly Portfolio Update Newsletter
28th May 20265:55 pmEQSHOL-Holding(s) in Company
27th May 20265:50 pmEQSHolding(s) in Company
20th May 20265:58 pmEQSHolding(s) in Company
19th May 20267:00 amEQSNotice of Full Year Results Presentations
18th May 20267:00 amEQSFurther partial realisation of holding in Revolut
7th May 20268:00 amRNS-RRelease of Monthly Portfolio Update Newsletter
1st May 20265:41 pmEQSHolding(s) in Company
1st May 20267:01 amEQSTotal Voting Rights
30th Apr 20268:01 amEQSHolding(s) in Company
27th Apr 20267:31 amEQSTransaction in Own Shares
27th Apr 20267:01 amEQSFull Year Trading Update
24th Apr 202610:11 amEQSHolding(s) in Company
23rd Apr 20264:38 pmEQSHolding(s) in Company
21st Apr 20264:28 pmEQSHolding(s) in Company
20th Apr 20267:01 amEQSTransaction in Own Shares
16th Apr 20263:26 pmEQSHolding(s) in Company
13th Apr 20267:01 amEQSTransaction in Own Shares
9th Apr 202610:41 amEQSHolding(s) in Company
7th Apr 20268:09 amEQSHolding(s) in Company
7th Apr 20267:01 amEQSTransaction in Own Shares
31st Mar 20265:31 pmEQSHolding(s) in Company
30th Mar 20267:01 amEQSTransaction in Own Shares
27th Mar 20264:31 pmEQSHolding(s) in Company
26th Mar 20267:01 amEQSTransaction in Own Shares
24th Mar 20267:01 amEQSTransaction in Own Shares
23rd Mar 20267:01 amEQSTransaction in Own Shares
20th Mar 20267:01 amEQSTransaction in Own Shares
19th Mar 20267:01 amEQSTransaction in Own Shares
19th Mar 20267:01 amEQSTransaction in Own Shares
18th Mar 20267:01 amEQSTransaction in Own Shares
17th Mar 20267:01 amEQSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20261:26 pmEQSHolding(s) in Company
16th Mar 20261:25 pmRNSHolding(s) in Company
16th Mar 20267:01 amEQSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:01 amEQSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:01 amEQSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:01 amEQSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.